Take your breakthroughs to market with complete confidence – backed by the leading tides partner with 50 years of peptides experience.
Go from inspired drug discovery to global growth, with research-grade material, refined process development and efficient GMP-grade large-scale production.
Perfect your Peptide Product
From simple peptides to the most complex peptidomimetics or synthetic proteins, our pipeline of customer peptide NCE projects includes both analytical services and process development:
Analytical services
- Product characterization
- Development and validation of analytical methods
- Stability studies
- Identification of impurities
Process development, characterization and qualification
- For all phases of clinical trials
- Commercial supply
Reach out to us and discover how you can achieve your goals.
Smoothing the journey to market with innovative peptide manufacturing
Avoid the risks involved with clinical and commercial milestones. We’ll formulate a clear plan for developing the chemistry, manufacturing, and control (CMC) of your peptide and oligonucleotide drug substances.
Years of interactions with regulatory authorities and sponsors around the world have gone into our general plan (below). But we’ll tailor the exact plan to precisely fit your needs – and your product.
Dedicated to sustainable peptide production
At Bachem, we are committed to sustainable peptide production practices that minimize environmental impact while maintaining the highest quality standards. We continuously seek innovative ways to reduce energy consumption, waste, and resource usage throughout the production process. By implementing green chemistry principles and sustainable technologies, we ensure that our peptide manufacturing is both environmentally responsible and efficient, supporting the global movement toward sustainability without compromising on the quality or safety of the therapeutics we produce.
Innovating for you
Innovation is part of our DNA and is more important now than ever, as it’s common to see modified or augmented peptide constructs. Peptides with unnatural amino acids, PEGylation, lipidation, glycosylation, imaging agents and structural constraint, are just few examples of what we encounter with today’s peptide-based entities.
We practise innovation by optimizing our supply chain, manufacturing unnatural amino acid derivatives in-house and meticulous characterization at intermediate stages. We also carefully evaluate peptide synthesis methodology, including liquid phase peptide synthesis, solid phase peptide synthesis or hybrid approaches.
Your business and products will also benefit from our toolbox of pioneering commercial manufacturing technology for peptides. From modern synthetic innovations like Molecular Hiving™ to continuous chromatography technology and an eco-conscious overall process, our approach is cutting edge.
Plus, our research committee is constantly evaluating new trends and technologies, and collaborating with academic groups and industry non-profits. So you’ll benefit from the very latest thinking and practices in peptides.
Why work with us?
- Excellence – We offer the highest quality products and services in the industry, with broad knowledge and expertise in peptide development and production.
- Internationally approved – Our facilities are regularly inspected by the FDA, Swissmedic and other prominent regulatory authorities – and we’re fully GMP compliant
- Expertise – Our people are highly skilled and passionate about emerging technologies, but also pride themselves on being reliable and committed to customers.
- Sustainability – We’re convinced that ethical behavior and integrity are essential for long-term business success, so we’re focused on improving our social, economic and environmental sustainability.
What our customers are saying
Peptide News
What are antimicrobial peptides?
Next peptide events coming up
Gordon Research Conference GRC
Gordon Research Conference GRC
Meet us at the Gordon Research Conference in Ventura, USA, from February 1-6.
Webinar Evaluation of linear SPPS vs. conjugation of SPPS-based fragments
Webinar Evaluation of linear SPPS vs. conjugation of SPPS-based fragments
In this webinar, we will compare linear Solid-Phase Peptide Synthesis (SPPS) with SPPS-based fragment conjugation, focusing on cost and scalability in large-scale production.
OPT Boston 2026
OPT Boston 2026
Meet our colleagues at OPT in Boston from March 18 to 19 to discuss your oligo projects with us.
NextGen Biomed 2026
NextGen Biomed 2026
Meet our colleagues in London from March 24 - 25. Listen to our on-site presentation
Full event calendar
Interested in joining at one of our exhibitions, conferences or webinars?
Peptide knowledge
Our Knowledge Center has a wide variety of tools and materials for peptide chemistry.
Peptide
calculator
Take a look >>
White
papers
Take a look >>
Webinars
Take a look >>
You might also be interested in…
Quality &
Regulatory
Take a look >>
GMP
Production
Take a look >>
Analytical
Capabilities
Take a look >>
Contact us